Cryptococcosis

13 registered clinical trials studyying Cryptococcosis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Prospective Observational Study on the Incidence of Opportunistic Fungal Infections NCT05707156	University of Colorado, Denver	—
Completed	Inpatient Package to Reduce HIV and AIDS-related Death in Zambia NCT04033718	University of Alabama at Birmingham	N/A
Completed	Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART NCT03993093	Singh, Ranjan Kumar, M.D.	—
Unknown	Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary No NCT04554875	Shanghai Pulmonary Hospital, Shanghai, China	—
Terminated	Cryptococcal Antigen Screening Plus Sertraline NCT03002012	University of Minnesota	Phase 3
Unknown	Vietnam Cryptococcal Retention in Care Study - Version 2.1 NCT03267407	National Hospital for Tropical Diseases, Hanoi, Vietnam	—
Unknown	Clinical Trial of Pulmonary Cryptococcosis in China NCT02503449	Zhixin Liang	—
Completed	Operational Research for Cryptococcal Antigen Screening NCT01535469	University of Minnesota	Phase 4
Recruiting	Vicente Ferrer HIV Cohort Study NCT02454569	Rural Development Trust Hospital	—
Completed	A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and NCT00784368	Janssen Pharmaceutical K.K.	Phase 3
Completed	A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections NCT00647907	Pfizer	Phase 4
Completed	Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neof NCT00001701	National Cancer Institute (NCI)	—
Recruiting	Fungal Infection Susceptibility NCT00001352	National Institute of Allergy and Infectious Diseases (NIAID)	—